QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.105.089987v1 315/2/494    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chakrabarti, S. Articles by Freedman, J. E. Search for Related Content PubMed PubMed Citation Articles by Chakrabarti, S. Articles by Freedman, J. E.

CARDIOVASCULAR

The Effect of Dipyridamole on Vascular Cell-Derived Reactive Oxygen Species

Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Massachusetts (S.C., O.V., S.V., J.E.F.); and Department of Physiology, University of Murcia Medical School, Murcia, Spain (D.I.)

Platelet and vascular stimulation leads to release of reactive oxygen species (ROS) that are known to influence vascular reactivity and thrombosis. Dipyridamole is a vasodilator and platelet inhibitor that has previously been shown to have direct antioxidant properties. The antioxidant effects of dipyridamole on vascular cell-derived ROS are not known; therefore, dipyridamole was incubated with endothelial cells and platelets and cellular redox status and release of endogenous ROS were assessed. Dipyridamole decreased intracellular basal ROS generation from endothelial cells as measured by DCFDA (2',7'-dichlorodihydrofluorescein diacetate) oxidation. Incubation of endothelial cells with dipyridamole also attenuated t-butylhydroperoxide-induced oxidative stress. Using a redox-sensitive fluorescent dye, dipyridamole improved cellular activity after treatment with t-butylhydroperoxide. Incubation with dipyridamole did not alter platelet release of nitric oxide or hydrogen peroxide but significantly attenuated superoxide release. Using flow cytometry and confocal microscopy, dipyridamole decreased platelet ROS generation. Dipyridamole also suppressed platelet-soluble CD40 ligand release. In summary, at therapeutically relevant concentrations, dipyridamole suppresses the formation of ROS in platelets and endothelial cells and improves cellular redox status. These data suggest that the redox-dependent properties of dipyridamole have a direct effect on vascular cells.

Address correspondence to: Dr. Jane E. Freedman, Boston University School of Medicine, 715 Albany Street, W507, Boston, MA 02118. E-mail: freedmaj{at}bu.edu

This article has been cited by other articles:

				J. E. Freedman Oxidative Stress and Platelets Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): s11 - s16. [Abstract] [Full Text] [PDF]

				H.-H. Kim and J. K. Liao Translational Therapeutics of Dipyridamole Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): s39 - s42. [Abstract] [Full Text] [PDF]

				V. L. Serebruany Hypokalemia, Cardiac Failure, and Reporting NXY-059 Safety for Acute Stroke Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2006; 11(4): 229 - 231. [Abstract] [PDF]

				C. J. Baglole, S. M. Bushinsky, T. M. Garcia, A. Kode, I. Rahman, P. J. Sime, and R. P. Phipps Differential induction of apoptosis by cigarette smoke extract in primary human lung fibroblast strains: implications for emphysema Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L19 - L29. [Abstract] [Full Text] [PDF]